[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![briefing_block_ Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1855826071666720768.png) Briefing Block [@briefing_block_](/creator/twitter/briefing_block_) on x 1479 followers
Created: 2025-07-16 11:14:42 UTC

@Investingcom Bank & Johnson & Johnson’s Q2 beat is impressive—but there’s more: strong oncology performance (Darzalex up ~$3.5B) and MedTech (+6 %) drove growth. They also raised full‑year EPS to ~$10.80‑10.90 and sales to $93.2‑93.6B, aided by tariff relief


XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945441961399435427/c:line.svg)

**Related Topics**
[tariffs](/topic/tariffs)
[$932936b](/topic/$932936b)
[eps](/topic/eps)
[medtech](/topic/medtech)
[$35b](/topic/$35b)

[Post Link](https://x.com/briefing_block_/status/1945441961399435427)